antibody arrays
Immunovia Raises $37.1M
The Swedish molecular diagnostics firm will use the proceeds, in part, to fund the planned launch of its Immray PanCan-d assay for detecting pancreatic cancer.
Over the next three years, Immunovia and its partners will use the firm's Immray PanCan-d assay to screen 6,000 diabetes patients for pancreatic cancer.
The company said that it can distinguish patients suffering from lupus from those with other autoimmune diseases using its antibody array platform.
Swiss Team Looks to Market DNA-Protein Binding Assay for Transcription Factor, ChIP Applications
Premium
SMiLE-seq combines antibody arrays, mechanical trapping, and next-generation sequencing readouts to provide a new platform for characterizing DNA-protein interactions.
Immunovia Conducts Study of Pancreatic Cancer Early Detection Test
The study, called Panfam-1, will analyze 1,000 individuals at high risk of familial pancreatic cancer over three years using the company's antibody array test.